Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine for Prevention of Type 2 Diabetes in Metabolic Syndrome
NCT00917449Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Dec 2005
- Primary completion
- Jun 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arginine in type 2 diabetes mellitus (T2DM), sponsored by IRCCS Ospedale San Raffaele. Started Dec 2005; status: completed.
02
Drugs
arginine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00917449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917449.